Pharma

US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore

US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore

Edited by Sandeep Singh (with inputs from agencies) | Saturday June 27, 2020

Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.

Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug

Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug

Edited by Sandeep Singh | Sunday June 21, 2020

Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.

Committee Rejects Former Fortis Promoter Malvinder Singh's Representation On Bail Criteria

Committee Rejects Former Fortis Promoter Malvinder Singh's Representation On Bail Criteria

Press Trust of India | Sunday June 21, 2020, New Delhi

The High Powered Committee said that Malvinder Mohan Singh was at liberty to file a bail application before courts concerned, which shall consider the same on merits in accordance with the law.

Glenmark Gets Approval For Favipiravir As COVID-19 Treatment

Glenmark Gets Approval For Favipiravir As COVID-19 Treatment

Reuters | Friday June 19, 2020

Favipiravir is made under the brand name Avigan by Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug there in 2014.

Zydus Cadila To Make Gilead's Potential COVID-19 Drug Remdesivir

Zydus Cadila To Make Gilead's Potential COVID-19 Drug Remdesivir

Reuters | Saturday June 13, 2020, Bengaluru

Remdesivir, intravenously administered in hospitals, has already been approved for emergency use in severely-ill patients in the United States, India and South Korea.

Zydus Cadila Signs Pact With Gilead To Make Remdesivir

Zydus Cadila Signs Pact With Gilead To Make Remdesivir

Reuters | Friday June 12, 2020

Antiviral drug remdesivir was the first treatment to show improvement in COVID-19 trials.

COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment

COVID-19 Crisis: Sun Pharma Testing Plant-Based Drug As Potential Treatment

Reuters | Friday June 05, 2020, Bengaluru

Drug makers around the world are rushing to develop a treatment or vaccine for the fast-spreading novel coronavirus that has killed over 3,90,000 people and ravaged financial markets.

Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment

Union Minister Piyush Goyal Meets Pharma Bosses, Announces Divestment

Reported by Sunil Prabhu, Edited by Abhik Deb | Sunday May 31, 2020

The minister said that India has been recognised as the Pharmacy of the World during the COVID-19 crisis

Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients

Sun Pharma To Test Pancreatitis Drug In COVID-19 Patients

Reuters | Friday May 29, 2020

The company joins other drugmakers Glenmark and Strides Pharma Science that are conducting trials in India for potential drugs for COVID-19.

In Virus Crisis, Drug And Consumer Stocks Soar In India

In Virus Crisis, Drug And Consumer Stocks Soar In India

Abhishek Vishnoi, Ronojoy Mazumdar and Ishika Mookerjee, Bloomberg | Friday May 22, 2020

The stockpiling of medicine in a country of 1.3 billion people and the rising focus on affordable health care globally will boost the shares of the nations pharmaceutical companies.

Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug

Strides Pharma To Conduct Trials In India For Potential COVID-19 Drug

Reuters | Thursday May 21, 2020, Bengaluru

Bengaluru-based Strides Pharma Science has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country.

Serum Institute To Make Crores Of Potential Coronavirus Vaccine Doses

Serum Institute To Make Crores Of Potential Coronavirus Vaccine Doses

Reuters | Thursday April 30, 2020

Serum, the world's largest maker of vaccines by volume, is mass-producing the vaccine candidate developed by the University of Oxford.

Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge

Glenmark To Conduct Clinical Trials For Potential COVID-19 Drug; Shares Surge

Edited by Abhishek Vasudev (with inputs from Reuters) | Thursday April 30, 2020

Glemark said the approval made it the first pharmaceutical company in India to be given the go-ahead to start trials on COVID-19 patients.

Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump

Glenmark Pharma To Conduct Trials For Potential COVID-19 Drug, Shares Jump

Reuters | Thursday April 30, 2020, Bengaluru

Glenmark Pharmaceuticals, which rose as much as 8.9 per cent to Rs 359, traded up 5.9 per cent at 9:37 am.

Sun Pharma Says Halol Unit Issues Not Likely To Impact Business, Shares Edge Higher

Sun Pharma Says Halol Unit Issues Not Likely To Impact Business, Shares Edge Higher

Edited by Sandeep Singh (with inputs from agencies) | Monday March 30, 2020

Sun Pharma said it continues to manufactureand distribute existing products for the US market.

1234...5